FREEDOM, SYNTAX, FAME and FUNCTIONALITY: the future of surgical revascularization in stable ischemic heart disease
1East Carolina Heart Institute, Brody School of Medicine at ECU, Greenville, NC, USA.
Insights
Coronary artery bypass grafting (CABG) has strong evidence for stable ischemic heart disease. However, evolving treatments may impact future CABG referrals, necessitating procedure optimization.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Cardiac Surgery
Background:
- Coronary artery bypass grafting (CABG) is a well-established revascularization procedure for stable ischemic heart disease.
- Recent evidence from large observational studies and randomized trials strongly supports the efficacy of CABG.
- The procedure has a robust historical and contemporary evidence base supporting its use.
Purpose of the Study:
- To evaluate the current evidence supporting coronary artery bypass grafting (CABG) for stable ischemic heart disease.
- To discuss the impact of the evolving revascularization landscape on future CABG indications.
- To explore potential modifications and optimizations for CABG in the contemporary medical environment.
Main Methods:
- Review of large-scale observational database analyses.
- Analysis of data from recent randomized controlled trials.
- Discussion of the changing landscape of revascularization therapies.
Main Results:
- Contemporary evidence strongly supports CABG for stable ischemic heart disease, aligning observational and trial data.
- The established evidence base for CABG is substantial and historically significant.
- The evolving field of revascularization presents challenges to the future relevance of current CABG evidence.
Conclusions:
- Despite robust evidence, the future role of CABG may be influenced by new revascularization techniques.
- Optimization and modification of CABG procedures are crucial for its continued application.
- The article discusses strategies for adapting CABG to the evolving treatment landscape for ischemic heart disease.
Abstract:
At the age of nearly 50 years, the procedure of coronary artery bypass grafting (CABG) now has the most solid evidence supporting its role in revascularization for stable ischemic heart disease in its history. In what is a relatively infrequent occurrence in medicine, the results from large-scale observational database analyses are now aligned with and supported by data from recent randomized trials, providing important contemporary evidence in support of CABG. However, even with strong evidence, the changing landscape of revascularization for stable ischemic heart disease threatens to make this evidence irrelevant in deciding which patients should be referred for CABG in the future. How the procedure of CABG could be modified and optimized for incorporation into this new landscape is discussed in this article.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Atherosclerosis III: Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations


